Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

NCT02727582 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT02727582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02727582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment
Lead sponsor
University of Cape Town
Phase
Observational
Overall status
Completed
Start date
July 30, 2015
Completion date
January 30, 2021
Enrollment
142 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug-resistant tuberculosis